13441-51-5
13441-51-5 結(jié)構(gòu)式
基本信息
D-2-氨基-4-[2-氨基苯基]-4-氧丁 酸
D-2-氨基-4-(2-氨基苯基)-4-氧代丁酸
D-犬尿氨酸
D-KYNURENINE
D-kynurenine free base
β-Anthraniloyl-D-alanine
(2R)-2-amino-4-(2-aminophenyl)-4-oxobutanoic acid
β-Anthraniloyl-D-alanine, D-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid
(R)-α,2-Diamino-γ-oxobenzenebutanoic acid
物理化學性質(zhì)
安全數(shù)據(jù)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-W014502R | 犬尿氨酸 D-Kynurenine (Standard) | 13441-51-5 | 5 mg | 600元 |
| 2026/06/05 | HY-W014502R | 犬尿氨酸 D-Kynurenine (Standard) | 13441-51-5 | 10 mg | 950元 |
| 2026/06/05 | HY-W014502R | 犬尿氨酸 D-Kynurenine (Standard) | 13441-51-5 | 25 mg | 1880元 |
常見問題列表
|
Human Endogenous Metabolite
|
D-kynurenine (10, 40, 60, and 100 μM) positively regulates the metastasis of 95D cells, a lung cancer cell line, which is reduced upon siRNAAhr treatment. Significant enhancement VIM expression was detected in the presence of D-kynurenine (10 and 40 μM). 10 μM D-kynurenine markedly attenuates E-cadherin level. 10 μM D-kynurenine-mediated changes of VIM and E-cadherin are substantially attenuated on siRNAAhr treatment as well. The evidences-10/40 μM D-kynurenine-induced up-regulation of CYP1A1, 10 μM D-kynurenine-induced increase of nuclear transfer of Ahr, and 10/40/60/100 μM D-kynurenine-induced enhancement of DER-luciferase activity-indicated that D-kynurenine Is capable of activating Ahr in fact.